Lincoln National Corp increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 7.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 7,314 shares of the medical research company’s stock after buying an additional 512 shares during the […]
Bahl & Gaynor Inc. lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,291 shares of the medical research company’s stock after selling 75 shares during the quarter. Bahl & […]
Spinnaker Trust lessened its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 5.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 875 shares of the medical research company’s stock after selling 50 shares during the […]
Truist Financial Corp decreased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 18.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,314 shares of the medical research company’s stock after selling 36,454 shares during […]
Delta Investment Management LLC trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 15.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,934 shares of the medical research company’s stock after selling 551 shares during the period. Delta Investment […]
Fisher Asset Management LLC increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 0.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,572,994 shares of the medical research company’s stock after acquiring an additional 1,917 shares during the quarter. Fisher […]
Anchor Capital Advisors LLC lowered its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,167 shares of the medical research company’s stock after selling 1,762 shares during the quarter. […]
Private Wealth Partners LLC lifted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 1.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 85,131 shares of the medical research company’s stock after purchasing an additional 815 […]
Intact Investment Management Inc. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 2,300 shares of the medical research company’s stock, valued at approximately $1,221,000. A number of other hedge funds also recently made changes to their positions in the stock. Alliance […]
Summit Financial LLC grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 5.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,814 shares of the medical research company’s stock after purchasing an additional 147 shares during the quarter. […]
Epic Trust Investment Advisors LLC lifted its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 31.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 928 shares of the medical research company’s stock after acquiring an additional 223 shares during the period. Epic […]
First Trust Direct Indexing L.P. lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 41.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,036 shares of the medical research company’s stock after buying an additional 1,187 […]